Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Wu CC
------>authors3_c=???
------>paper_class1=2
------>Impact_Factor=None
------>paper_class3=0
------>paper_class2=0
------>vol=28
------>confirm_bywho=lm
------>insert_bywho=ccwu
------>Jurnal_Rank=None
------>authors4_c=
------>comm_author=
------>patent_EDate=None
------>authors5_c=
------>publish_day=12
------>paper_class2Letter=None
------>page2=61
------>medlineContent=
------>unit=E0117
------>insert_date=20060502
------>iam=1
------>update_date=None
------>author=???
------>change_event=4
------>ISSN=
------>authors_c=???
------>score=104
------>journal_name=International Journal of Andrology - Abstract of the 8th International Congress of Andrology
------>paper_name=Transdermal testosterone gel increase the serum testosterone level in hypogonadal men
------>confirm_date=20060502
------>tch_id=077009
------>pmid=11134099
------>page1=61
------>fullAbstract=Transdermal delivery of testosterone (T) represents an effective alternative to injectable androgens. Transdermal T patches normalize serum T levels and reverse the symptoms of androgen deficiency in hypogonadal men. However, the acceptance of the closed system T patches has been limited by skin irritation and/or lack of adherence. T gels have been proposed as delivery modes that minimize these problems. In this study we examined the pharmacokinetic profiles after 1, 30, 90, and 180 days of daily application of 2 doses of T gel (50 and 100 mg T in 5 and 10 g gel, delivering 5 and 10 mg T/day, respectively) and a permeation-enhanced T patch (2 patches delivering 5 mg T/day) in 227 hypogonadal men. This new 1% hydroalcoholic T gel formulation when applied to the upper arms, shoulders, and abdomen dried within a few minutes, and about 9-14% of the T applied was bioavailable. After 90 days of T gel treatment, the dose was titrated up (50 mg to 75 mg) or down (100 mg to 75 mg) if the preapplication serum T levels were outside the normal adult male range. Serum T rose rapidly into the normal adult male range on day 1 with the first T gel or patch application. Our previous study showed that steady state T levels were achieved 48-72 h after first application of the gel. The pharmacokinetic parameters for serum total and free T were very similar on days 30, 90, and 180 in all treatment groups. After repeated daily application of the T formulations for 180 days, the average serum T level over the 24-h sampling period (C(avg)) was highest in the 100 mg T gel group (1.4- and 1.9-fold higher than the C(avg) in the 50 mg T gel and T patch groups, respectively). Mean serum steady state T levels remained stable over the 180 days of T gel application. Upward dose adjustment from T gel 50 to 75 mg/day did not significantly increase the C(avg), whereas downward dose adjustment from 100 to 75 mg/day reduced serum T levels to the normal range for most patients. Serum free T levels paralleled those of serum total T, and the percent free T was not changed with transdermal T preparations. The serum dihydrotestosterone C(avg) rose 1.3-fold above baseline after T patch application, but was more significantly increased by 3.6- and 4.6-fold with T gel 50 and 100 mg/day, respectively, resulting in a small, but significant, increase in the serum dihydrotestosterone/T ratios in the two T gel groups. Serum estradiol rose, and serum LH and FSH levels were suppressed proportionately with serum T in all study groups; serum sex hormone-binding globulin showed small decreases that were significant only in the 100 mg T gel group. We conclude that transdermal T gel application can efficiently and rapidly increase serum T and free T levels in hypogonadal men to within the normal range. Transdermal T gel provided flexibility in dosing with little skin irritation and a low discontinuation rate.
------>tmu_sno=None
------>sno=13578
------>authors2=Chiang HS
------>authors3=Hwang TIS
------>authors4=
------>authors5=
------>authors6=
------>authors6_c=
------>authors=Wu CC
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=???
------>publish_area=2
------>updateTitle=Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=Suppl
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2005
------>submit_flag=None
------>publish_month=6
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z